AMED Amedisys Inc.

Amedisys Announces First Quarter 2021 Earnings Release and Conference Call Date

Amedisys Announces First Quarter 2021 Earnings Release and Conference Call Date

BATON ROUGE, La., April 14, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and personal care, will report results for the first quarter ended March 31, 2021, after the market closes on April 28, 2021. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on April 29, 2021.

To participate on the conference call, please call a few minutes before 11:00 a.m. ET to either (877) 524-8416 (toll-free) or (412) 902-1028 (toll). A replay of the call will be available through May 29, 2021, by dialing (877) 660-6853 (toll-free) or (201) 612-7415 (toll) and entering access ID 13718528.

A live webcast of the call will be accessible through the Company website on the Investor Relations section at .

About Amedisys:

Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,900 hospitals and 78,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With approximately 21,000 employees, in 514 care centers in 39 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 418,000 patients in need every year. For more information about the Company, please visit: .

Contact:

Nick Muscato Kendra Kimmons
Amedisys, Inc. Amedisys, Inc.
Investor Relations Media Relations
855.259.2046 225.299.3720
   





EN
14/04/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Amedisys Inc.

 PRESS RELEASE

Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results

Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results BATON ROUGE, La., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2023. Three-Month Periods Ended December 31, 2023 and 2022 Net service revenue increased $8.8 million to $570.8 million compared to $562.0 million in 2022. Prior year included $15.9 million of net service revenue from our personal care business which was divested on March 31, 2023.Net income attributable to Amedisys, Inc. of $19.3 million, which is...

 PRESS RELEASE

Amedisys Offers Molecular Testing for Rapid and Accurate Infection Dia...

Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis BATON ROUGE, La., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is now offering advanced molecular testing to its care centers nationwide. This innovative collaboration with Patient Choice Laboratories utilizes molecular testing for the swift and precise identification of pathogens in urine, respiratory and wound infections. By leveraging the latest in diagnostic technology, Amedisys aims to improve the quality of infe...

 PRESS RELEASE

Amedisys Reports Third Quarter 2023 Financial Results

Amedisys Reports Third Quarter 2023 Financial Results BATON ROUGE, La., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2023. Three-Month Periods Ended September 30, 2023 and 2022 Net service revenue decreased $1.8 million to $556.2 million compared to $558.0 million in 2022. Prior year included $16.6 million of net service revenue from our personal care business which was divested on March 31, 2023.Net income attributable to Amedisys, Inc. of $26.0 million compared to $25.6 mi...

 PRESS RELEASE

Amedisys Celebrates National Quality Week

Amedisys Celebrates National Quality Week Held October 15-21, this Observance Shines a Light on Our Commitment to Quality Care BATON ROUGE, La., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is proud to celebrate National Quality Week October 15-21, 2023. This week-long observance serves as an opportunity for Amedisys to recognize and highlight the organization's commitment to delivering the highest standard of quality care. During National Quality Week, Amedisys will focus on the importance...

 PRESS RELEASE

Amedisys Recognizes Suicide Prevention Awareness Month and Promotes th...

Amedisys Recognizes Suicide Prevention Awareness Month and Promotes the 988 Suicide & Crisis Lifeline BATON ROUGE, La., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is proud to recognize September as Suicide Prevention Awareness Month and join the efforts to raise awareness for suicide prevention and mental health. In support of this important cause, Amedisys is highlighting the 988 Suicide and Crisis Lifeline which makes it easier for individuals in crisis to access crucial resources and assi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch